Published: December 23rd 2024 | Updated: January 23rd 2025
Bone Predominant mCRPC Patient Case
Published: May 7th 2024 | Updated: May 21st 2024
FDA accepts BLA for subcutaneous nivolumab in solid tumors
Published: June 7th 2025 | Updated: June 9th 2025
FDA authorizes Expanded Access Program of Anktiva for lymphopenia
Published: June 5th 2025 | Updated: June 9th 2025
Zanzalintinib plus nivolumab shows safety, efficacy for stage 4 RCC
Published: June 4th 2025 | Updated: June 9th 2025
Adding niraparib to AAP extends rPFS in HRR-positive mCSPC
Published: June 3rd 2025 | Updated: June 9th 2025
Enzalutamide plus ADT continues to show durable survival benefit in mHSPC at 5 years